Koninklijke Dsm Nv Stock Net Asset
| KDSKFDelisted Stock | USD 25.30 0.00 0.00% |
Koninklijke DSM NV fundamentals help investors to digest information that contributes to Koninklijke DSM's financial success or failures. It also enables traders to predict the movement of Koninklijke Pink Sheet. The fundamental analysis module provides a way to measure Koninklijke DSM's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Koninklijke DSM pink sheet.
Koninklijke |
Koninklijke DSM NV Company Net Asset Analysis
Koninklijke DSM's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Koninklijke DSM Net Asset | 16.01 B |
Most of Koninklijke DSM's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Koninklijke DSM NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Koninklijke DSM NV has a Net Asset of 16.01 B. This is much higher than that of the Basic Materials sector and significantly higher than that of the Specialty Chemicals industry. The net asset for all United States stocks is notably lower than that of the firm.
Koninklijke Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Koninklijke DSM's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Koninklijke DSM could also be used in its relative valuation, which is a method of valuing Koninklijke DSM by comparing valuation metrics of similar companies.Koninklijke DSM is currently under evaluation in net asset category among its peers.
Koninklijke Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0402 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 23.38 B | |||
| Shares Outstanding | 172.97 M | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 56.99 % | |||
| Price To Earning | 37.75 X | |||
| Price To Book | 2.12 X | |||
| Price To Sales | 2.27 X | |||
| Revenue | 9.2 B | |||
| Gross Profit | 3.16 B | |||
| EBITDA | 1.71 B | |||
| Net Income | 1.68 B | |||
| Cash And Equivalents | 1.63 B | |||
| Cash Per Share | 9.44 X | |||
| Total Debt | 2.84 B | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 2.51 X | |||
| Book Value Per Share | 56.38 X | |||
| Cash Flow From Operations | 1.43 B | |||
| Earnings Per Share | 6.71 X | |||
| Price To Earnings To Growth | 2.88 X | |||
| Number Of Employees | 21.76 K | |||
| Beta | 0.71 | |||
| Market Capitalization | 22.49 B | |||
| Total Asset | 16.01 B | |||
| Working Capital | 2.7 B | |||
| Current Asset | 4.9 B | |||
| Current Liabilities | 2.2 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 16.01 B | |||
| Last Dividend Paid | 2.63 |
About Koninklijke DSM Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Koninklijke DSM NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Koninklijke DSM using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Koninklijke DSM NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Koninklijke Pink Sheet
If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |